Send to

Choose Destination
Mol Psychiatry. 2013 Apr;18(4):443-50. doi: 10.1038/mp.2013.17. Epub 2013 Mar 5.

The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophrenia.

Author information

Centre for Addiction and Mental Health, Toronto, ON, Canada [2] Institute of Medical Science, University of Toronto, Toronto, ON, Canada.

Erratum in

  • Mol Psychiatry. 2013 Oct;18(10):1146. Chakavarty, M M [corrected to Chakravarty, M M].


We examined the influence of the genome-wide significant schizophrenia risk variant rs1625579 near the microRNA (miRNA)-137 (MIR137) gene on well-established sources of phenotypic variability in schizophrenia: age-at-onset of psychosis and brain structure. We found that the MIR137 risk genotype strongly predicts an earlier age-at-onset of psychosis across four independently collected samples of patients with schizophrenia (n=510; F1,506=17.7, P=3.1 × 10(-5)). In an imaging-genetics subsample that included additional matched controls (n=213), patients with schizophrenia who had the MIR137 risk genotype had reduced white matter integrity (F3,209=13.6, P=3.88 × 10(-8)) throughout the brain as well as smaller hippocampi and larger lateral ventricles; the brain structure of patients who were carriers of the protective allele was no different from healthy control subjects on these neuroimaging measures. Our findings suggest that MIR137 substantially influences variation in phenotypes that are thought to have an important role in clinical outcome and treatment response. Finally, the possible consequences of genetic risk factors may be distinct in patients with schizophrenia compared with healthy controls.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center